臨床前影像市場規模、佔有率和成長分析（按組件、模式、應用和地區分類）—2025-2032年產業預測

全球臨床前影像市場規模預計在 2023 年達到 36 億美元，從 2024 年的 37.7 億美元成長到 2032 年的 54.9 億美元，在預測期（2025-2032 年）內複合年成長率為 4.8%。

受藥物研發、分子生物學和轉化醫學領域對先進研究儀器的需求不斷成長的推動，臨床前成像市場正經歷強勁成長。該領域對於評估新藥候選藥物的療效和安全性、了解疾病進展以及支持個人化醫療的發展至關重要。包括癌症和神經系統疾病在內的慢性疾病日益普遍，使得利用精準、非侵入性的影像技術分析動物模型中的疾病機制變得特別重要。高解析度磁振造影（MRI）、正子斷層掃描（PET）、電腦斷層掃描（CT）和多模態影像系統等技術的進步，正在提升我們即時觀察細胞和分子層面疾病的能力。此外，人工智慧和機器學習在影像分析中的應用，也得益於該領域投資和合作的不斷成長，從而提高了分析的準確性和效率。

全球臨床前影像市場促進因素

慢性疾病（包括癌症和神經系統疾病）的日益普遍，推動了人們對注重準確性和非侵入性的創新臨床前成像技術的興趣。這種需求的成長在製藥和生物製藥公司中尤其明顯，這些公司正在利用這些先進的影像工具來評估藥物療效、追蹤疾病進展並最佳化治療策略。此外，對快速、全面的藥物研發流程的需求不斷成長，也促使人們對高解析度和多模態成像技術進行大量投資，進一步推動了全球臨床前影像市場的成長，因為相關人員在尋求改善研究成果和治療方案。

限制全球臨床前影像市場的因素

全球臨床前影像市場面臨部署和維護成像系統高成本的嚴峻挑戰。這種經濟負擔尤其對開發中國家的小型實驗室、Start-Ups和研究機構構成障礙。高解析度磁振造影（MRI）、正子斷層掃描/電腦斷層掃描（PET/CT）和混合系統等先進影像技術不僅需要大量的初始投資，還需要持續投入資金用於系統校準、軟體升級、維護和耗材。此外，聘用和培訓操作這些先進系統的專業人員也增加了營運成本，並對追求尖端研究能力構成重大挑戰。

全球臨床前影像市場趨勢

全球臨床前影像市場正呈現出一個顯著的趨勢，其驅動力是人工智慧 (AI) 和機器學習 (ML) 技術的日益普及。這些先進工具透過實現自動化影像分析、精確的組織分割和更精準的生物標記識別，正在革新診斷影像領域。隨著研究人員積極採用 AI 和 ML，他們受益於更少的人工干預和更高的準確性，從而能夠從複雜的影像數據中獲得更深入的洞察。這一趨勢不僅提高了臨床前試驗的整體效率，也加速了關鍵發現的進程，推動了生物醫學研究和藥物開發的創新與進步。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

臨床前影像市場規模（按組件分類）及複合年成長率（2025-2032 年）

• 市場概覽
• 硬體系統
• 軟體和服務

依影像方式分類的臨床前影像市場規模及複合年成長率（2025-2032 年）

• 市場概覽
• 磁振造影（MRI）
• 正子斷層掃描（PET）
• 電腦斷層掃描（CT）
• 光學成像
• 超音波成像
• 單光子發射電腦斷層掃描（SPECT）
• 多模態成像

按應用領域分類的臨床前影像市場規模及複合年成長率（2025-2032 年）

• 市場概覽
• 藥物發現與開發
• 疾病研究
• 轉換醫學
• 毒理學研究

臨床前影像市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2024 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2024 年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2022-2024年營收年比比較

主要企業簡介

• Bruker Corporation（USA）
• Revvity, Inc.（USA）
• FUJIFILM VisualSonics Inc.（Canada）
• Mediso Medical Imaging Systems Ltd.（Hungary）
• MR Solutions（UK）
• Aspect Imaging Limited（USA）
• TriFoil Imaging（USA）
• MILabs BV（Netherlands）
• Siemens Healthineers AG（Germany）
• General Electric（GE）HealthCare Technologies Inc.（USA）
• Cubresa Inc.（Canada）
• Berthold Technologies GmbH & Co. KG（Germany）
• Miltenyi Biotec GmbH（Germany）
• Li-Cor Biosciences（USA）
• Sofie（USA）
• Advanced Molecular Vision（UK）
• Vieworks Co., Ltd.（South Korea）
• Kub Technologies（USA）
• Medikors Inc.（South Korea）
• SCANCO Medical AG（Switzerland）

結論與建議

Global Preclinical Imaging Market size was valued at USD 3.6 billion in 2023 and is poised to grow from USD 3.77 billion in 2024 to USD 5.49 billion by 2032, growing at a CAGR of 4.8% during the forecast period (2025-2032).

The preclinical imaging market is witnessing robust expansion, driven by heightened demand for sophisticated research instruments utilized in drug discovery, molecular biology, and translational medicine. This segment is essential for assessing the efficacy and safety of novel drug candidates, understanding disease progression, and aiding in the creation of personalized therapies. The escalating prevalence of chronic ailments, including cancer and neurological disorders, necessitates precise, non-invasive imaging methods for analyzing disease mechanisms in animal models. Advances in technology, such as high-resolution MRI, PET, CT, and multimodal imaging systems, enhance researchers' capabilities for real-time visualization at cellular and molecular levels. Additionally, the integration of AI and machine learning in imaging analysis is refining accuracy and increasing data analysis efficiency, fueled by growing investments and collaborations in the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preclinical Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Preclinical Imaging Market Segments Analysis

Global Preclinical Imaging Market is segmented by Component, Modality, Application and region. Based on Component, the market is segmented into Hardware Systems and Software & Services. Based on Modality, the market is segmented into Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT), Optical Imaging, Ultrasound Imaging, Single Photon Emission Computed Tomography (SPECT) and Multimodal Imaging. Based on Application, the market is segmented into Drug Discovery & Development, Disease Research, Translational Medicine and Toxicology Studies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Preclinical Imaging Market

The escalating prevalence of chronic diseases, including cancer and neurological disorders, is driving a surge in interest for innovative preclinical imaging techniques that prioritize accuracy and non-invasiveness. This heightened demand is particularly evident among pharmaceutical and biopharmaceutical companies, which utilize these advanced imaging tools to assess drug efficacy, track disease progression, and refine treatment strategies. Additionally, the pressing need for expedited and thorough drug discovery processes is prompting substantial investments in high-resolution and multimodal imaging technologies, further propelling the growth of the global preclinical imaging market as stakeholders seek to enhance research outcomes and therapeutic solutions.

Restraints in the Global Preclinical Imaging Market

The Global Preclinical Imaging market faces significant constraints due to the high costs associated with the acquisition and maintenance of imaging systems. This financial burden can particularly hinder smaller laboratories, startups, and research institutions in developing countries. Advanced imaging technologies, including high-resolution MRI, PET/CT, and hybrid systems, entail not only substantial initial investments but also ongoing expenses for system calibration, software upgrades, maintenance, and consumables. Furthermore, the need to hire or train skilled personnel to operate these sophisticated systems contributes additional operational expenses, posing a considerable challenge in the pursuit of cutting-edge research capabilities.

Market Trends of the Global Preclinical Imaging Market

The Global Preclinical Imaging market is witnessing a significant trend driven by the rising incorporation of artificial intelligence (AI) and machine learning (ML) technologies. These advanced tools are revolutionizing the imaging landscape by facilitating automated image analysis, precise tissue segmentation, and enhanced biomarker identification. As researchers increasingly embrace AI and ML, they benefit from reduced manual workload and improved accuracy, enabling deeper insights from complex imaging data. This trend not only enhances the overall efficiency of preclinical studies but also accelerates the discovery of critical observations, fostering innovation and advancements in biomedical research and drug development.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Preclinical Imaging Market Size by Component & CAGR (2025-2032)

• Market Overview
• Hardware Systems
• Software & Services

Global Preclinical Imaging Market Size by Modality & CAGR (2025-2032)

• Market Overview
• Magnetic Resonance Imaging (MRI)
• Positron Emission Tomography (PET)
• Computed Tomography (CT)
• Optical Imaging
• Ultrasound Imaging
• Single Photon Emission Computed Tomography (SPECT)
• Multimodal Imaging

Global Preclinical Imaging Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery & Development
• Disease Research
• Translational Medicine
• Toxicology Studies

Global Preclinical Imaging Market Size & CAGR (2025-2032)

• North America (Component, Modality, Application)
  • US
  • Canada
• Europe (Component, Modality, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Modality, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Modality, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Modality, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM VisualSonics Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Medical Imaging Systems Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MR Solutions (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aspect Imaging Limited (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TriFoil Imaging (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MILabs B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric (GE) HealthCare Technologies Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cubresa Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berthold Technologies GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Li-Cor Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sofie (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Molecular Vision (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vieworks Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kub Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medikors Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SCANCO Medical AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations